Check out your Company Bowl for anonymous work chats.
At Verily we respect individuals’ privacy through our commitment to Privacy By Design (PbD) principles. This approach is globally recognized as a best practice to embed privacy protections into the design of systems, products, and processes from the very beginning, making personal data protection a core feature, not an add-on. Our PbD commitment is backed by experts in the field, dedicated employees, well-defined processes, and cutting-edge technology, ensuring we consistently promote a corporate culture of privacy as well as sustaining confidence with our business partners and individuals who entrust us with their personal data.
Tune into the Bright Spots in Healthcare podcast with Verily's Associate Chief Clinical Officer, Carolyn Bradner Jasik, MD! Dr. Jasik discusses precision health, the strategy behind our consumer health app Verily Me, and her vision for how AI, data, and clinical care can come together to meaningfully engage and support patients.
What if you could move beyond static, fragmented real-word data (RWD) and have an ongoing conversation with research participants? Watch the on-demand webinar to learn how Verily Viewpoint Evidence transforms research into a dynamic dialogue with direct connections to engaged, re-contactable individuals.
Go under the hood of Verily Me, our new consumer health app powered by Verily Pre, our AI-native platform for precision health. Building this complex, data-intensive application could only be done with a platform-first approach.
At the JPM Healthcare Conference this week, our CEO Stephen Gillett presented Verily’s core strategy aligned with our mission to bring the promise of precision health to everyone, every day. If you weren’t able to be there in person, here are the highlights: ❇️ Solving the data silo problem: 97% of healthcare data is inaccessible and not fit to be analyzed for healthcare. Verily is building the infrastructure to connect, standardize, and activate this data to be AI-ready. ❇️ Verily Pre: Our strategy is built around this AI-native precision health platform designed to harmonize and enrich multimodal data for use in healthcare AI, using our proprietary FHIR-based clinical model. ❇️ Dual DNA of tech and healthcare: Verily was born from Google X, The Moonshot Factory and partnered early with a provider group to deliver care in all 50 states. We have a decade of experience delivering chronic care programs, and designing and executing clinical studies. Verily's expertise enables us to serve patients and customers with the regulatory, safety and clinical standards that are critical to healthcare, while developing leading technologies to help our customers adopt AI safely. ❇️ Key partnerships: We’re collaborating with NVIDIA to integrate their AI capabilities into Verily Pre, and partnering with the University of Colorado on AI-powered research and care.
Meet Verily Pre, our platform designed to accelerate AI for precision health. Pre is the cornerstone of our data and tech infrastructure, transforming complex, multimodal healthcare datasets for use in healthcare AI. It includes three complementary solutions: ❇️ Refinery: Our powerful curation engine for structured, research and AI-ready data assets ❇️ Exchange: A centralized forum for sharing and accessing datasets, models, and agents ❇️ Workbench: Our highly scalable trusted research environment used by over 20K researchers today
🔮 What’s your prediction for health AI in 2026? Our Chief Product Officer, Myoung Cha, weighed in on the STAT AI Prognosis predictions, foreseeing a big shift: a majority of patients will use AI before a doctor visit. Read more expert predictions from Brittany Trang and see what’s on your own bingo card for the future of health tech.
"With NVIDIA's cutting-edge AI capabilities now available in our Verily Pre platform, we are providing researchers with unparalleled tools to enhance the speed and efficiency of AI model development and omics analysis, ultimately accelerating the understanding of disease and advancing precision health for everyone." - Stephen Gillett, Verily CEO If you’ll be at the J.P. Morgan Healthcare Conference next week, you can hear more from Stephen Gillett on Tuesday, January 13 at 5:30 PM PT at the Westin Saint Francis in San Francisco.
What if you could connect health data to better predict and prevent negative outcomes, and make care more precise? Watch to see how Verily Pre can help get you there.
Our CEO Stephen Gillett will be at the J.P. Morgan Healthcare Conference discussing Verily's business updates and how Verily Pre, our precision health platform, is enabling healthcare AI for our customers and users. 🗓️ Tuesday, January 13th at 5:30 PM PT 📍 Westin St. Francis, Mission Bay Room, San Francisco, CA
